In a transgene-induced mammary tumor model, interference with GRP78 function exhibited dramatic reduction in the microvessel density of endogenous mammary tumors with no effect on normal organs, and a follow-up study demonstrated that interference with GRP78 function suppressed tumor growth and angiogenesis during the early phase of tumor growth (64). Here, HSPA5 is linked to breast cancer.